X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (87) 87
index medicus (76) 76
male (48) 48
female (47) 47
adult (42) 42
schizophrenia (37) 37
original (36) 36
psychiatry (36) 36
middle aged (34) 34
public aspects of medicine (31) 31
drugs (27) 27
pharmaceutical industry (27) 27
business (26) 26
quality of life (26) 26
original research article (25) 25
life sciences (24) 24
analysis (23) 23
france (23) 23
patients (22) 22
health care sciences & services (21) 21
public health (21) 21
europe (19) 19
pharmacology & pharmacy (19) 19
health policy (18) 18
human health and pathology (18) 18
santé publique et épidémiologie (18) 18
studies (18) 18
cost-effectiveness (17) 17
economics and finance (17) 17
humanities and social sciences (17) 17
[ sdv.spee ] life sciences [q-bio]/santé publique et épidémiologie (16) 16
clinical trials (16) 16
marketing (16) 16
psychiatrics and mental health (16) 16
psychology (16) 16
[ shs.eco ] humanities and social sciences/economies and finances (15) 15
adolescent (15) 15
decision making (15) 15
health policy & services (15) 15
[ sdv.mhep.psm ] life sciences [q-bio]/human health and pathology/psychiatrics and mental health (14) 14
aged (14) 14
cohort studies (14) 14
cost-benefit analysis (14) 14
health economics (14) 14
schizophrenic psychology (14) 14
economics (13) 13
health care economics and organizations (13) 13
mortality (13) 13
research (13) 13
young adult (13) 13
[ shs.psy ] humanities and social sciences/psychology (12) 12
depression (12) 12
orphan drugs (12) 12
pharmaceuticals (12) 12
pricing (12) 12
quality (12) 12
research article (12) 12
health care policy (11) 11
health technology assessment (11) 11
medicine (11) 11
medicine & public health (11) 11
medicine, general & internal (11) 11
public health, environmental and occupational health (11) 11
rare diseases (11) 11
research & development--r&d (11) 11
article (10) 10
care and treatment (10) 10
efficacy (10) 10
funding (10) 10
market access (10) 10
medicine, research & experimental (10) 10
pharmacoeconomics (10) 10
prevalence (10) 10
reimbursement (10) 10
schizophrenia - diagnosis (10) 10
united kingdom (10) 10
cost analysis (9) 9
cost control (9) 9
costs (9) 9
drug therapy (9) 9
internal medicine (9) 9
mental disorders (9) 9
models, economic (9) 9
population (9) 9
retrospective studies (9) 9
surveys and questionnaires (9) 9
diagnosis (8) 8
disease (8) 8
germany (8) 8
health care (8) 8
medical care, cost of (8) 8
models (8) 8
original article (8) 8
pharmacology (8) 8
risk factors (8) 8
burden (7) 7
care (7) 7
cross-cultural comparison (7) 7
epidemiology (7) 7
health care costs (7) 7
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2017, ISBN 1315314606, xxvii, 175 pages
Market access is the fourth hurdle in the drug development process and the primary driver for global income of any new drug. Without a strategy in place for... 
Drugs | Marketing | Industry & industrial studies | Chemistry | Pharmaceutical Medicine | Pharmaceutical Science Regulatory | Pharmaceutical Science | Drug Discovery | Clinical Implementation | Pharmaceutical industry
Book
Medecine/Sciences, ISSN 0767-0974, 05/2018, Volume 34, pp. 45 - 47
Journal Article
Epidemiology Biostatistics and Public Health, 12/2016, Volume 13, Issue 4
An editorial perspective on Barbieri and Capri article: Is vaccination good value for money? A review of cost-utility analyses of vaccination strategies in... 
Journal Article
Journal of Market Access & Health Policy, 01/2015, Volume 3, Issue 1
Journal Article
Journal of Market Access & Health Policy, ISSN 2001-6689, 01/2015, Volume 3, Issue 1, p. 29204
Journal Article
Journal of Market Access & Health Policy, ISSN 2001-6689, 01/2013, Volume 1, Issue 1, p. 21835
  The late 1990's and early 2000's saw a large number of cost containment measures which, however, failed to control the expenditure. [...]faced with rapidly... 
Generic products | Indexing services | Open access publishing | Sensitivity analysis | Health care policy | Journals | GATS | Research | Society | Pharmaceutical industry | Patients
Journal Article
Journal of Market Access & Health Policy, ISSN 2001-6689, 01/2019, Volume 7, Issue 1, p. 1545514
Non-profit drug research and development (R&D) has the potential to deliver innovative treatments at affordable prices. Using the case study methodology, we... 
research and development | pharmaceutical industry | Non-profit | ethics | orphan drugs | pricing | non-profit
Journal Article
Pharmaceutical Research, ISSN 0724-8741, 3/2018, Volume 35, Issue 3, pp. 1 - 6
Journal Article
Multiple Sclerosis, ISSN 1352-4585, 08/2016, Volume 22, Issue 2 Suppl, pp. 60 - 70
Journal Article
European Journal of Clinical Pharmacology, ISSN 0031-6970, 4/2013, Volume 69, Issue 4, pp. 1 - 10
Journal Article
International Journal of Technology Assessment in Health Care, ISSN 0266-4623, 2017, Volume 33, Issue S1, pp. 128 - 129
INTRODUCTION:Value added medicines (VAM) are medicines based on known molecules that address healthcare needs and deliver relevant improvements for patients,... 
Medical personnel | Health care | Medicine | Drug delivery systems | Identification methods | Technology | Decision making | Value added | Technology assessment | Corporate planning | Patients
Journal Article
Journal Article
BMC Health Services Research, ISSN 1472-6963, 01/2019, Volume 19, Issue 1, pp. 22 - 14
Journal Article